Adrian Hepner
CIK 1637347 · Chief Medical Officer · last filed 2023-03-01
Adrian Hepner is a Chief Medical Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for COYA, was dated Mar 1, 2023. Current disclosed insider exposure totals $47.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$47.4K
2
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COYA | Chief Medical Officer | 10,000 | $4.74 | $47.4K | $0 | 2 | 2023-03-01 |
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | EVP and Chief Medical Officer | 48,784 | $2.14 | $104.4K | $0 | 6 | 2020-01-27 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-01 | COYA | Grant (A) | — | $0 | EDGAR |
| 2023-01-04 | COYA | Buy (P) | +10,000 | $0 | EDGAR |
| 2020-01-27 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −1,630 | -$94.5K | EDGAR |
| 2020-01-07 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +23,185 | -$46.8K | EDGAR |
| 2019-01-25 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +18,229 | -$31.9K | EDGAR |
| 2018-01-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
| 2017-01-06 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-05 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |